NEW YORK – S2 Genomics said on Wednesday that it has signed distribution agreements with Scrum, PharmiGene, LnCBio, Thunderbio Science, and TrendBio to promote, sell, and support S2's Singulator 100 system as well as associated products for single-cell genomics and cell biology applications in the Asia-Pacific region.
The firm's agreements will cover Japan (Scrum), South Korea, (LnCBio and Thunderbio Science), Taiwan (PharmiGene), as well as Australia and New Zealand (TrendBio).